These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 221399)

  • 1. Sequential changes in cell-mediated immune responses to herpes simplex virus following primary herpetic infection in man.
    Shillitoe EJ; Wilton JM; Lehner T
    IARC Sci Publ (1971); 1978; (24 Pt 2):753-8. PubMed ID: 221399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immunity and herpesvirus infections in cardiac-transplant patients.
    Rand KH; Rasmussen LE; Pollard RB; Arvin A; Merigan TC
    N Engl J Med; 1977 Jun; 296(24):1372-7. PubMed ID: 193008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration.
    Russell AS; Kaiser J; Lao VS
    J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody.
    Meyers-Elliott RH; Chitjian PA
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice.
    Mogensen SC
    Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and in Vitro demonstration of cellular immunity to DNA and RNA viruses in guinea-pigs.
    Koszinowski U; Bandlow G
    Clin Exp Immunol; 1975 Apr; 20(1):143-54. PubMed ID: 173485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity to herpes simplex virus in man.
    Russell AS
    J Infect Dis; 1974 Feb; 129(2):142-6. PubMed ID: 4359402
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential changes in cell-mediated immune responses to herpes simplex virus after recurrent herpetic infection in humans.
    Shillitoe EJ; Wilton JM; Lehner T
    Infect Immun; 1977 Oct; 18(1):130-7. PubMed ID: 198372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains.
    Chang YJ; Jiang M; Lubinski JM; King RD; Friedman HM
    Vaccine; 2005 Sep; 23(38):4658-65. PubMed ID: 15936852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity in herpetic keratitis measured by leukocyte migration inhibition.
    Polack FM; Habash N; Zam ZS; Burdette MG
    Ann Ophthalmol; 1982 Sep; 14(9):825-7. PubMed ID: 6295252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients.
    Arvin AM; Pollard RB; Rasmussen LE; Rand KH; Merigan TC
    IARC Sci Publ (1971); 1978; (24 Pt 2):745-51. PubMed ID: 221398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of human lymphocytes by Herpes simplex virus antigens.
    Starr SE; Karatela SA; Shore SL; Duffey A; Nahmias AJ
    Infect Immun; 1975 Jan; 11(1):109-12. PubMed ID: 163788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients.
    Pollard RB; Arvin AM; Gamberg P; Rand KH; Gallagher JG; Merigan TC
    Am J Med; 1982 Nov; 73(5):679-87. PubMed ID: 6291387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depressed herpes simplex virus-induced lymphocyte blastogenesis in individuals with severe recurrent herpes infections.
    El Araby II; Chernesky MA; Rawls WE; Dent PB
    Clin Immunol Immunopathol; 1978 Feb; 9(2):253-63. PubMed ID: 201413
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunology of herpesvirus infection: immunity to herpes simplex virus in eye infections.
    Meyers RL; Chitjian PA
    Surv Ophthalmol; 1976; 21(2):194-204. PubMed ID: 185741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus.
    Hayward AR; Herberger MJ; Groothuis J; Levin MR
    J Immunol; 1984 Nov; 133(5):2469-73. PubMed ID: 6207230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-mediated immunity to herpes simplex virus in man.
    Russell AS
    Am J Clin Pathol; 1973 Dec; 60(6):826-30. PubMed ID: 4357123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.